glp-1 prescriptions growth slowing 2024 The trend: What the real-world data reveals GLP-1 Receptor Agonist Market Size

June 2025: A 2025 study published in JAMA Ophthalmology has found a connection between taking tirzepatide drugs like Mounjaro and developing NAION

In addition to controlling blood sugar and supporting weight loss, GLP-1 drugs, and SGLT-2 inhibitors offer other significant benefits

[DOI] [PMC free article] [PubMed] 87.Senduran N, Yadav HN, Vishwakarma VK, Bhatnagar P, Gupta P, Bhatia J, et al

Wenzels diverse life experience and extensive training in family medicine, emergency care, nutrition, and hormone replacement therapies give him the unique platform to provide unmatched care for his patients.

Animal studies were approved by the Italian Ministero della Salute, Ufficio VI (authorization numbers 1060/2015) and by the Ethics Committee of the University of Padova